SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-271445
Filing Date
2021-09-13
Accepted
2021-09-13 16:16:10
Documents
14
Period of Report
2021-09-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d216131d8k.htm   iXBRL 8-K 29957
2 EX-10.1 d216131dex101.htm EX-10.1 62111
3 EX-10.2 d216131dex102.htm EX-10.2 494868
  Complete submission text file 0001193125-21-271445.txt   845955

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alvr-20210908.xsd EX-101.SCH 2889
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20210908_lab.xml EX-101.LAB 19657
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20210908_pre.xml EX-101.PRE 12313
7 EXTRACTED XBRL INSTANCE DOCUMENT d216131d8k_htm.xml XML 3591
Mailing Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142
Business Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 211249862
SIC: 2836 Biological Products, (No Diagnostic Substances)